Pancreatic cancer continues to be one of the deadliest cancers with a 5-year survival rate of only 9% (American Cancer Society). The challenges associated with pancreatic cancer stem from late diagnosis, limited therapeutic options, and the complex biology of the disease. However, promising advances are being made on multiple fronts to improve early detection and develop more effective...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian